Investigation on the use of fused deposition modeling for the production of IR dosage forms containing Timapiprant

Investigation on the use of fused deposition modeling for the production of IR dosage forms containing Timapiprant

The present work focused on evaluating the feasibility of fused deposition modeling (FDM) in the development of a dosage form containing Timapiprant (TMP), also known as CHF6532, which is a novel active molecule indicated in the potential treatment of eosinophilic asthma upon oral administration. Th...

Full description

Bibliographic Details
Main Authors: Marco Uboldi, Arianna Chiappa, Marisa Pertile, Alessandro Piazza, Stefano Tagliabue, Anastasia Foppoli, Luca Palugan, Andrea Gazzaniga, Lucia Zema, Alice Melocchi
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:International Journal of Pharmaceutics: X
Subjects:
3D printing
Immediate release
Oral administration
BCS class II drug
Personalized therapy
Dissolution
Online Access:http://www.sciencedirect.com/science/article/pii/S2590156722000433

Internet

http://www.sciencedirect.com/science/article/pii/S2590156722000433

Similar Items